Starpharma Holdings Ltd Sustainability Reports
Starpharma Holdings Limited is a biotechnology company focused on the research, development, and commercialization of dendrimer products for pharmaceutical and healthcare applications. Its operations center primarily on its proprietary DEP drug delivery platform and products such as VivaGel and Viraleze.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
LEI: 254900WRGE3OUSWGMB55
FIGI: BBG001SFBLL1
28 reports from 2006 to 2026